Researchers buoyed by novel HIV drugs: will expand drug arsenal against resistant virus.
Stephenson
Joan
J
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003510:Cyclohexanes / Q000627:therapeutic use; D024882:Drug Resistance, Viral; D015507:Drugs, Investigational / Q000627:therapeutic use*; D023581:HIV Fusion Inhibitors / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use; D006801:Humans; D000077592:Maraviroc; D009930:Organic Chemicals / Q000627:therapeutic use; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014230:Triazoles / Q000627:therapeutic use
D019380:Anti-HIV Agents; D003510:Cyclohexanes; D015507:Drugs, Investigational; D023581:HIV Fusion Inhibitors; D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D014230:Triazoles; D000068898:Raltegravir Potassium; D000077592:Maraviroc